Nemaura Med (NMRD) Stock Price, News & Analysis
Company Description
Nemaura Med (OTC Link: NMRD) is classified in the medical devices industry within the Healthcare sector and carries a market capitalization of $4.0K.
NMRD has gained 0.0% over the past year. Shares last traded at $0.0001.
This page collects what Stock Titan holds for NMRD, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Nemaura Med (NMRD) stock last closed at $0.0001. Over the past 12 months, the stock has gained 0.0%. At a market capitalization of $4.0K, NMRD is classified as a micro-cap stock with approximately 40.4M shares outstanding.
Latest News
Nemaura Med has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include earnings, management, AI, conferences. View all NMRD news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Nemaura Med (NMRD) currently stands at 365 shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Nemaura Med (NMRD) currently stands at 1.0 days, down 99.9% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has decreased 80.3% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
NMRD Company Profile & Sector Positioning
Nemaura Med (NMRD) operates in the Medical Devices industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing NMRD often look at related companies in the same sector, including Pressure Bio (PBIO), Thermogenesis Holdings Inc (THMO), Opgen (OPGN), Manhattan Scientifics Inc (MHTX), and Alr Technologies (ALRTF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate NMRD's relative position within its industry.